General FDA clears trial of dual-targeted CAR T-cell therapy for cancerBy Healthcare Propulsion StaffSeptember 12, 20260 The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a…
